Loading...

IMRX IMMUNEERING CORP Capital Structure Changes 8-K Filing

MMNR

MRX

IMMUNEERING CORP

(IMRX)

2025 8-K

Financial Results Report

Clinical Trial Update

Financial Results Announced

Stock Offering Details

Securities Purchase Agreement

Private Placement Raised

Quarterly Results Update

Clinical Trials

Financial Statements

Financial Results

Clinical Trial Update

Clinical Trial Update

Financial Results

Director Appointment

Clinical Trial Update

Financial Results Announcement

Annual Meeting of Stockholders

Repricing of Options

Appointment of Director

Financial Results Announcement

Amendments to Bylaws

Financial Results Announcement

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Public Offering

Results of Operations and F...

Financial Results Announcement

External Links:

On August 21, 2025, Immuneering Corporation announced a private placement of 6,329,113 shares and warrants, generating approximately $25 million. This event is significant from an equity investor perspective.

AI Assistant

IMMUNEERING CORP

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.